Jonathan Fior was born in Los Angeles, USA, in 1982, to Italian parents. Jonathan’s parents moved back to Italy when he was a child, and he completed his education in Italy, a country known for its excellence in the education department. He was always fascinated by medical and computer science and graduated with a bachelor's degree in medical biotechnology from the University of Milan, Italy. As well as maturating experience as software developer by developing his own apps. Upon graduation he immediately started working in the field of HIV research, with the goal of bringing innovation to the field. In this regard, he conceived the idea of using irradiated SupT1 cells as a decoy target for HIV-1 to prevent CD4+ T cell depletion as well as to render the virus less cytotoxic. Jonathan explored this approach in an in vitro setting in his 2012 publication, proposing SupT1 cell infusion as a possible cell-based HIV therapy. He then wanted to explore this novel therapeutic approach in an in vivo setting. He decided to start his own research company and founded Innovative Bioresearch in 2014. He later conducted a groundbreaking pilot study exploring SupT1 cell infusion therapy for HIV in humanized mice and was the first research scientist to believe in the potential of blockchain technology to disrupt pharma, issuing INNBC (InnovativeBioresearchCoin) in 2018 becoming what can be considered the og creator of decentralized science (DeSci). He is also the author of what can be considered the most comprehensive scientific paper on the Salamander regeneration process, how it compares with human healing, and how it can be a model for developing novel regenerative and anticancer therapies. Recently, he published the first official peer-reviewed decentralized science (DeSci) study, demonstrating the real world use of INNBC DApp for blockchain-based biomedical data storage and sharing, on Springer-Nature network, leading publisher of the world's most prestigious scientific journals.